Template:Classic TB drugs: Difference between revisions
Jump to navigation
Jump to search
Ttenbergen (talk | contribs) mNo edit summary |
Ttenbergen (talk | contribs) mNo edit summary |
||
| Line 11: | Line 11: | ||
* additionally from [[Resistance to antimicrobials, anti-mycobacterial agent]]: | * additionally from [[Resistance to antimicrobials, anti-mycobacterial agent]]: | ||
** amikacin, kanamycin, capreomycin, viomycin, enviomycin, | ** amikacin, kanamycin, capreomycin, viomycin, enviomycin, | ||
** ethionamide, prothionamide, cycloserine, terizidone | ** anti-tb drugs: [https://en.wikipedia.org/wiki/Ethionamide ethionamide], [https://en.wikipedia.org/wiki/Prothionamide prothionamide], https://en.wikipedia.org/wiki/Cycloserine cycloserine], [https://en.wikipedia.org/wiki/Terizidone terizidone] | ||
Revision as of 13:48, 2020 March 17
This template maintains consistency in the concept of antimycobacterials is used in several situations in our data collection:
Ethambutal (Ethambutol; Etibi), Isoniazid (INH), Rifabutin (mycobutin), Pyrazinamide (rifater), Rifampicin, Rifampin, Streptomycin
- additionally from Resistance to antimicrobials, anti-mycobacterial agent:
- amikacin, kanamycin, capreomycin, viomycin, enviomycin,
- anti-tb drugs: ethionamide, prothionamide, https://en.wikipedia.org/wiki/Cycloserine cycloserine], terizidone